Amylyx received FDA Fast Track designation for AMX0114, an investigational antisense oligonucleotide targeting knockdown of calpain-2, for people living with amyotrophic lateral sclerosis (ALS) in ...

The purpose of this study was to document the extent of variation in individual growth rates and its fitness consequences among several populations of an indeterminate grower, the western terrestrial ...